Literature DB >> 17181741

MICA and MICB overexpression in oral squamous cell carcinoma.

Chung-Ji Liu1, Man-Tin Lui, Hsin-Lan Chen, Shu-Chun Lin, Kuo-Wei Chang.   

Abstract

BACKGROUND: The concentration of MICA in serum seems be a good candidate marker in cancer. Previous studies from our laboratory have shown that the polymorphic MIC gene may confer a risk for oral squamous cell carcinoma (OSCC). The study investigated the expression levels of MICA and MICB of OSCC patients and cancer cell lines.
MATERIAL AND METHODS: We used RT-PCR to analyze the mRNA expression of MICA and MICB in four oral cancer cell lines compared with three normal human oral keratinocyte (NHOK) cell lines and in tissues from 36 patients with OSCC comparing tumor tissue with non-cancerous matched tissue (NCMT).
RESULTS: Endogenous MICB mRNA expression in OSCC cell lines was significantly higher than that in NHOK (1.40 +/- 0.27 vs. 0.40 +/- 0.16; P = 0.04). In 20 of 36 sets of tissue from patients with OSCC, MICB mRNA expression was higher in the cancerous tissue than in the NCMT. The mean MICB mRNA expression in OSCC tissues was significantly higher than in NCMT (0.39 +/- 0.08 vs. 0.14 +/- 0.03, P = 0.009, paired t-test). A significantly lower MICA mRNA was found in patients who chewed areca nut compared with those who did not use areca (P = 0.001) and in patients with well-differentiated tumors compared with those with less well-differentiated tumors (P = 0.02).
CONCLUSION: MICA and MICB mRNA expression may be increased in OSCC but there appears to be individual variation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17181741     DOI: 10.1111/j.1600-0714.2006.00471.x

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  7 in total

1.  Soluble MICA is elevated in pancreatic cancer: Results from a population based case-control study.

Authors:  Guillaume Onyeaghala; Heather H Nelson; Bharat Thyagarajan; Amy M Linabery; Angela Panoskaltsis-Mortari; Myron Gross; Kristin E Anderson; Anna E Prizment
Journal:  Mol Carcinog       Date:  2017-05-24       Impact factor: 4.784

2.  MHC I-related chain a expression in gastric carcinoma and the efficacy of immunotherapy with cytokine-induced killer cells.

Authors:  Yu Chen; Jing Lin; Zeng-Qing Guo; Wan-Song Lin; Zhi-Feng Zhou; Chuang-Zhong Huang; Qiang Chen; Yun-Bin Ye
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

3.  Membrane progesterone receptors (mPRs) mediate progestin induced antimorbidity in breast cancer cells and are expressed in human breast tumors.

Authors:  Gwen E Dressing; Rebecca Alyea; Yefei Pang; Peter Thomas
Journal:  Horm Cancer       Date:  2012-06       Impact factor: 3.869

4.  Expression of MICA in oral squamous carcinoma cells and its effect on NK cells.

Authors:  Shunjin Chen; Mingang Ying; Xiuan Lin; Xiong Zheng; Chang Liu; Hui Liu
Journal:  Int J Clin Exp Med       Date:  2015-10-15

5.  Proteasome regulation of ULBP1 transcription.

Authors:  James E Butler; Mikel B Moore; Steven R Presnell; Huei-Wei Chan; N Jan Chalupny; Charles T Lutz
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

6.  Immunotherapy for lung cancers.

Authors:  Ming-Yi Ho; Shye-Jye Tang; Kuang-Hui Sun; Winnie Yang
Journal:  J Biomed Biotechnol       Date:  2011-01-24

7.  Elevation of soluble major histocompatibility complex class I related chain A protein in malignant and infectious diseases in Chinese patients.

Authors:  Xiaoxin Jiang; Ju-Fang Huang; Zhi Huo; Qiuqui Zhang; Yan Jiang; Xiaoping Wu; Yanwen Li; Guanmin Jiang; Leping Zeng; Xiao-Xin Yan; Ping Yu; Renxian Cao
Journal:  BMC Immunol       Date:  2012-11-26       Impact factor: 3.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.